Pages that link to "Q40535929"
Jump to navigation
Jump to search
The following pages link to Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. (Q40535929):
Displaying 50 items.
- Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice (Q24815069) (← links)
- Cytokine-Induced Modulation of Colorectal Cancer (Q26752374) (← links)
- Potentiality of immunotherapy against hepatocellular carcinoma (Q26784228) (← links)
- Interleukin 12: still a promising candidate for tumor immunotherapy? (Q26861559) (← links)
- In-situ tumor vaccination: Bringing the fight to the tumor (Q26991976) (← links)
- Endoscopic ultrasound: an overview of its role in current clinical practice (Q30363551) (← links)
- Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL. (Q33730717) (← links)
- Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy (Q33753431) (← links)
- Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates (Q33822191) (← links)
- IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms (Q34026026) (← links)
- Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases (Q34114153) (← links)
- Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model (Q34427459) (← links)
- New insights into IL-12-mediated tumor suppression. (Q34436897) (← links)
- Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer (Q35086111) (← links)
- Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. (Q35567765) (← links)
- Gene therapy of liver diseases (Q35842662) (← links)
- Gene therapy applications of viral vectors (Q35904004) (← links)
- Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains. (Q35939476) (← links)
- Antisense therapy for restenosis following percutaneous coronary intervention. (Q36040825) (← links)
- Trials of gene therapy for pancreatic carcinoma (Q36137459) (← links)
- Gene- and immunotherapy for hepatocellular carcinoma (Q36150432) (← links)
- Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity. (Q36190053) (← links)
- Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12. (Q36220613) (← links)
- Histone deacetylase inhibitors for treatment of hepatocellular carcinoma (Q36237743) (← links)
- Gene therapy imaging in patients for oncological applications. (Q36265644) (← links)
- The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression (Q36294870) (← links)
- Therapy of cancer by cytokines mediated by gene therapy approach (Q36394987) (← links)
- Virotherapy, gene transfer and immunostimulatory monoclonal antibodies. (Q36456487) (← links)
- Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity (Q36483435) (← links)
- New therapies for hepatocellular carcinoma. (Q36519041) (← links)
- Pancreatic cancer: a review of recent advances (Q36623071) (← links)
- Recent clinical progress in virus-based therapies for cancer. (Q36627242) (← links)
- Cancer gene therapy targeting angiogenesis: an updated review (Q36655133) (← links)
- Molecular mechanisms of pancreatic cancer and potential targets of treatment (Q36758436) (← links)
- Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression (Q36930091) (← links)
- Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy (Q37111931) (← links)
- Immunotherapy for liver tumors: present status and future prospects. (Q37144014) (← links)
- Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma. (Q37452091) (← links)
- Pancreatic cancer: gene therapy approaches and gene delivery systems (Q37621562) (← links)
- Systemic therapy for advanced hepatocellular carcinoma: past, present, and future (Q37734197) (← links)
- The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. (Q37800217) (← links)
- New approaches to the development of adenoviral dendritic cell vaccines in melanoma (Q37820489) (← links)
- Recent developments in prostate cancer biomarker research: therapeutic implications (Q37827186) (← links)
- Gene therapy of liver diseases: A 2011 perspective (Q37903546) (← links)
- Current and future management strategies for relapsed or progressive hepatoblastoma (Q38019027) (← links)
- Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy (Q38056365) (← links)
- Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives (Q38099680) (← links)
- Hepatocellular carcinoma: systemic therapies and future perspectives (Q38246965) (← links)
- Th1 cytokine-based immunotherapy for cancer. (Q38259461) (← links)
- Developments in cancer vaccines for hepatocellular carcinoma (Q38533017) (← links)